Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
-house sequencing platform and applies a wide range of advanced sequencing-based technologies including single-cell and spatial transcriptomics. Target systems include cell culture models, advanced mouse
-
Do you want to work with the newest long-read sequencing technologies? And do you see yourself as a team player who is strong in collaboration? If yes, we look forward to reading your application
-
that align with training goals for healthcare professionals. Prepare supporting training materials, guidelines, and user instructions. Our expectations of you We are looking for a candidate who has A PhD or
-
of the art equipment within DNA and RNA sequencing, laboratory automation, CPU and GPU compute resources, proteomics, metabolomics, and advanced microscopy. This position offers an excellent opportunity
-
for flow cytometry, imaging, next-generation sequencing and cell engineering. Terms of employment The average weekly working hours are 37 hours per week. The position is a fixed-term position limited to a
-
animal model trials, confocal microscopy and cell culture Desirable experience and skills: Research experience in antimicrobial resistance Experience in whole-genome sequencing and metagenomic analysis
-
alignment between scientific and development activities, partner coordination, stakeholder management, and fulfillment of strategic milestones. You will further be working closely with the IBIS Director, Vice
-
antimicrobial resistance and reference laboratory–level AMR work Have strong hands-on experience with phenotypic AST methods, including broth microdilution Have experience with whole-genome sequencing and
-
expected to bridge multiple scientific disciplines and contribute to deepening our understanding of how glycoengineered EVs can serve as precision drug delivery platforms and novel therapies. As part of your
-
expected to bridge multiple scientific disciplines and contribute to deepening our understanding of how glycoengineered EVs can serve as precision drug delivery platforms and novel therapies. As part of your